Pinchera Biagio, Trucillo Emilia, D'Agostino Alessia, Gentile Ivan
Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples "Federico II", Via Sergio Pansini 5, 80131 Naples, Italy.
Microorganisms. 2024 Oct 31;12(11):2217. doi: 10.3390/microorganisms12112217.
Urinary tract infections are one of the main complications in kidney transplant patients, with a significant impact on graft function and survival. In fact, it is estimated that up to 74% of kidney transplant patients experience at least one episode of UTIs in the first year after transplantation, with an increased risk of graft loss and an increased risk of mortality. Several risk factors have been identified, such as female gender, old age, diabetes mellitus, immunosuppression, pre-transplant UTIs, urinary tract abnormalities, and prolonged dialysis. The worsening burden of antimicrobial resistance is also in itself a risk factor and a major complication in evolution and management. The management of prophylaxis, asymptomatic bacteriuria, and UTIs is still an open challenge, with some points to be clarified. Faced with such scenarios, our review aimed to evaluate the current epidemiology, examine the risk factors, and consider all the possibilities and methods of management, giving a current view and evaluation of the topic.
尿路感染是肾移植患者的主要并发症之一,对移植肾功能和患者存活有重大影响。事实上,据估计,高达74%的肾移植患者在移植后的第一年至少经历一次尿路感染,移植肾丢失风险增加,死亡风险也增加。已确定了几个风险因素,如女性、老年、糖尿病、免疫抑制、移植前尿路感染、尿路异常和长期透析。抗菌药物耐药性负担的加重本身也是一个风险因素,并且是疾病进展和管理中的主要并发症。预防性治疗、无症状菌尿和尿路感染的管理仍然是一个有待解决的挑战,有些问题尚待阐明。面对这些情况,我们的综述旨在评估当前的流行病学,研究风险因素,并考虑所有可能的管理方法,对该主题给出当前的观点和评估。